GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (STU:7NS0) » Definitions » Additional Paid-In Capital

Palisade Bio (STU:7NS0) Additional Paid-In Capital : €124.28 Mil(As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Additional Paid-In Capital?


Palisade Bio's quarterly additional paid-in capital declined from Sep. 2023 (€124.17 Mil) to Dec. 2023 (€121.71 Mil) but then increased from Dec. 2023 (€121.71 Mil) to Mar. 2024 (€124.28 Mil).

Palisade Bio's annual additional paid-in capital increased from Dec. 2021 (€90.27 Mil) to Dec. 2022 (€114.83 Mil) and increased from Dec. 2022 (€114.83 Mil) to Dec. 2023 (€121.71 Mil).


Palisade Bio Additional Paid-In Capital Historical Data

The historical data trend for Palisade Bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Additional Paid-In Capital Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
42.25 90.27 114.83 121.71

Palisade Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.96 120.59 124.17 121.71 124.28

Palisade Bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Palisade Bio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Palisade Bio (STU:7NS0) Business Description

Traded in Other Exchanges
Address
5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (STU:7NS0) Headlines

No Headlines